FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11506211000001105: Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42259201000001118 Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43207301000001116 Mintezol 500mg/5ml oral suspension (Imported (United States)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Is a Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Has active ingredient Tiabendazole false Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Has specific active ingredient Tiabendazole true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) 120 ml Is pack of False Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Inferred relationship Existential restriction modifier
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) 120 ml Has AMP True Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start